Inventor profile of:

Mark Smith

City:

San Francisco, California

Country:

United States

Published Applications:

27

Last publication date:

2025-10-23

Top Assignees for applications by Mark Smith

The entities that hold a legal rights for patent applications filed by inventor Smith Mark:

Recent patent applications by Smith Mark

Mark Smith from San Francisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-23
US20250326725A1
Chemistry; metallurgy

PI4-Kinase Inhibitors and Methods of Using the Same

#2 | 2022-09-15
US20220289775A1
Chemistry; metallurgy

ENPP1 Inhibitors and Methods of Modulating Immune Response

#3 | 2022-05-19
US20220153711A1
Chemistry; metallurgy

P14-Kinase Inhibitors and Methods of Using the Same

#4 | 2022-03-03
US20220062243A1
Human necessities

P14-Kinase Inhibitors with Anti-Cancer Activity

#5 | 2022-01-20
US20220017507A1
Chemistry; metallurgy

PI-kinase inhibitors with anti-infective activity

#6 | 2021-12-02
US20210369747A1
Human necessities

ENPP1 inhibitors and their use for the treatment of cancer

#7 | 2021-07-08
US20210205292A1
Human necessities

INHIBITORS OF CREB-CBP INTERACTION FOR TREATMENT OF LEUKEMIA

#8 | 2020-12-17
US20200390898A1
Human necessities

KNOTTIN-DRUG CONJUGATES AND METHODS OF USING THE SAME

#9 | 2020-06-25
US20200197431A1
Human necessities

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

#10 | 2019-02-28
US20190062323A1
Chemistry; metallurgy

PI-kinase inhibitors with anti-infective activity

#11 | 2018-07-19
US20180200280A1
Human necessities

4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication

#12 | 2018-06-21
US20180170924A1
Chemistry; metallurgy

PI-kinase inhibitors with anti-infective activity

#13 | 2017-10-26
US20170304342A1
Human necessities

Knottin-drug conjugates and methods of using the same

#14 | 2017-10-19
US20170296664A1
Human necessities

4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication

#15 | 2017-08-17
US20170232031A1
Human necessities

Inhibitors of Zika Virus

#16 | 2016-09-15
US20160264611A1
Chemistry; metallurgy

4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication

#17 | 2016-08-18
US20160237106A1
Chemistry; metallurgy

4'-AZIDO SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF EBOLA VIRUS RNA REPLICATION

#18 | 2016-08-04
US20160220596A1
Human necessities

4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication

#19 | 2016-07-07
US20160194314A1
Chemistry; metallurgy

Pi-kinase inhibitors with anti-infective activity

#20 | 2015-08-13
US20150225441A1
Chemistry; metallurgy

4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication

#21 | 2014-12-18
US20140369959A1
Chemistry; metallurgy

4′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication

#22 | 2014-11-20
US20140341848A1
Chemistry; metallurgy

4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication

#23 | 2014-11-20
US20140341847A1
Chemistry; metallurgy

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

#24 | 2009-01-08
US20090012034A1
Chemistry; metallurgy

Non-nucleoside reverse transcriptase inhibitors

#25 | 2007-04-05
US20070078128A1
Chemistry; metallurgy

Non-nucleoside reverse transcriptase inhibitors

#26 | 2006-02-23
US20060040890A1
Chemistry; metallurgy

Anti-viral nucleosides

#27 | 2005-01-25
US10717260
-

Antiviral nucleoside derivatives

InventorID:

974918 ⎘